RxDoctor Payments Data

Monica Jackson

Family · Gallipolis, OHNPI 1912522442

Payments from drug & device makers

$272in general payments, 2019–2025

Across 18 payments — averaging $15.10 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$149
  • AbbVie$32
  • Sanofi Pasteur Inc.$17
  • Exact Sciences$16
  • Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$15
  • Dynavax Technologies Corporation$14
  • plus $27 from 2 others

What the payments were for

  • Food & beverage$272100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$272 in reported general payments places this provider in the 45th percentile of 6,812 family providers in Ohio.

See all family providers in Ohio

Medicare billing

Part B allowed, 2024
$23,784
Medicare patients
109
Services billed
454

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
JardianceEmpagliflozin25$36,151
EliquisApixaban45$30,451
OzempicSemaglutide25$27,644
XareltoRivaroxaban22$15,993
FarxigaDapagliflozin Propanediol21$15,258
Tresiba Flextouch U-100Insulin Degludec21$11,594
EntrestoSacubitril/Valsartan16$10,821
Trelegy ElliptaFluticasone/Umeclidin/Vilanter16$9,579
Stiolto RespimatTiotropium Br/Olodaterol Hcl12$5,580
SymbicortBudesonide/Formoterol Fumarate20$4,868
Varenicline Tartrate16$3,393
LantusInsulin Glargine,hum.Rec.Anlog17$2,370
DilantinPhenytoin Sodium Extended12$2,323
Albuterol Sulfate HfaAlbuterol Sulfate85$2,249
Insulin Lispro Kwikpen U-100Insulin Lispro13$2,183

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Boehringer IngelheimJardiance, Stiolto Respimat$14$41,73137 claims
AstraZenecaFarxiga, Symbicort$149$20,12641 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 45th percentile of 6,812 family providers in Ohio.

Other family in Gallipolis

See the full list for Ohio

Where these figures come from

Is this you, or does something look wrong? →